Literature DB >> 21115939

Cytology on transbronchial needle aspiration (TBNA): not only for lung cancer.

Pierdonato Bruno1, Lara Pisani, Alberto Ricci, Carlo Falasca, Enrico Giarnieri, Salvatore Mariotta, Maria Rosaria Giovagnoli.   

Abstract

Transbronchial needle aspiration (TBNA) is a bronchoscopic technique allowing the sampling of cytological/histological material from mediastinal lymph nodes. TBNA is routinely used only in few centers for the staging of lung cancer, and even less frequently for the diagnosis of mediastinal metastases from extrapulmonary tumors. We illustrate 5 cases of mediastinal metastases from extrapulmonary tumors observed at our center in order to emphasize the usefulness of cytology and TBNA in the diagnosis of these pathologies. The 5 cases illustrated were: seminoma, uterine cervical carcinoma, pleural mesothelioma, pancreatic carcinoma, pericardial mesothelioma. In these 5 cases, albeit not of lung cancer, the cytology on TBNA allowed the rapid formulation of the correct diagnosis; its main advantage is that it can be performed during a simple fiberbronchoscopy under local anesthesia with less risk and at a lower cost than a computed tomography-guided needle biopsy or mediastinoscopy.

Entities:  

Mesh:

Year:  2010        PMID: 21115939

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  The value of cell block based on fine needle aspiration for lung cancer diagnosis.

Authors:  Zhengwei Dong; Hui Li; Jun Zhou; Wei Zhang; Chunyan Wu
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

2.  Endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of intrathoracic lymphadenopathy in patients with extrathoracic malignancy: a multicenter study.

Authors:  Neal Navani; Matthew Nankivell; Ian Woolhouse; Richard N Harrison; Mohammed Munavvar; Ute Oltmanns; Mary Falzon; Gabrijela Kocjan; Robert C Rintoul; Sam M Janes
Journal:  J Thorac Oncol       Date:  2011-09       Impact factor: 15.609

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.